These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 6093512

  • 1. Interpretation of susceptibility testing of ceftriaxone.
    Squires E, Cleeland R, Christenson J, Boehni E.
    Am J Med; 1984 Oct 19; 77(4C):12-6. PubMed ID: 6093512
    [Abstract] [Full Text] [Related]

  • 2. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
    Jones RN, Craig WA, Ambrose PG, Dudley MN, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2005 Jul 19; 52(3):235-46. PubMed ID: 16105568
    [Abstract] [Full Text] [Related]

  • 3. [The correlation between the MICs deduced from Showa disk method and the MICs determined by micro-dilution method].
    Moroizumi S, Kasitani F, Isikawa M, Iwata M, Ohno A, Yamaguchi K.
    Rinsho Byori; 1994 Oct 19; 42(10):1062-8. PubMed ID: 7996716
    [Abstract] [Full Text] [Related]

  • 4. In vitro study with ciprofloxacin: interpretive criteria of agar diffusion test according to standards of the NCCLS and DIN.
    Grimm H.
    Am J Med; 1987 Apr 27; 82(4A):376-80. PubMed ID: 3578326
    [Abstract] [Full Text] [Related]

  • 5. Interpretation criteria for sensitivity testing of ceftriaxone in agar diffusion test according to the DIN 58940 method.
    Grimm H.
    Chemotherapy; 1984 Apr 27; 30(1):49-53. PubMed ID: 6319090
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial activity of ceftriaxone: a review.
    Cleeland R, Squires E.
    Am J Med; 1984 Oct 19; 77(4C):3-11. PubMed ID: 6093515
    [Abstract] [Full Text] [Related]

  • 7. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies.
    Gums JG, Boatwright DW, Camblin M, Halstead DC, Jones ME, Sanderson R.
    Ann Pharmacother; 2008 Jan 19; 42(1):71-9. PubMed ID: 18094350
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Influence of antibiotic disk charge on concordance curve of cefotaxime ].
    Drugeon HB, Seon M, Reynaud A, Chung SS, Courtieu AL.
    Pathol Biol (Paris); 1982 Jun 19; 30(6 Pt 2):517-21. PubMed ID: 6289229
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Colistin susceptibility testing by Etest and disk diffusion methods.
    Galani I, Kontopidou F, Souli M, Rekatsina PD, Koratzanis E, Deliolanis J, Giamarellou H.
    Int J Antimicrob Agents; 2008 May 19; 31(5):434-9. PubMed ID: 18328674
    [Abstract] [Full Text] [Related]

  • 12. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
    Butt T, Khan MY, Ahmad RN, Salman M, Afzal RK.
    J Coll Physicians Surg Pak; 2006 Jan 19; 16(1):31-4. PubMed ID: 16441985
    [Abstract] [Full Text] [Related]

  • 13. [Statistical regression analysis for four new cephalosporins (author's transl)].
    Sirot D, Glanddier Y, Chanal M, Sirot J, Cluzel R.
    Pathol Biol (Paris); 1982 Jun 19; 30(6):357-62. PubMed ID: 6287389
    [Abstract] [Full Text] [Related]

  • 14. [Usefulness of the disk diffusion method for evaluating the sensitivity of Neisseria meningitidis to penicillin and cefotaxime].
    Joyanes P, Martínez-Martínez L, Pascual A, Suárez AI, Perea EJ.
    Enferm Infecc Microbiol Clin; 1997 Dec 19; 15(10):515-8. PubMed ID: 9522515
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial susceptibility tests with cefotaxime and correlation with clinical bacteriologic response.
    Thornsberry C, Jones RN, Barry AL, Fuchs PC.
    Rev Infect Dis; 1982 Dec 19; 4 Suppl():S316-24. PubMed ID: 6294780
    [Abstract] [Full Text] [Related]

  • 16. [A study of the disc sensitivity test for cefotaxime].
    Kanazawa Y, Kuramata T, Matsumoto K.
    Jpn J Antibiot; 1982 Jul 19; 35(7):1730-6. PubMed ID: 6294354
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL, Jacobus NV, Tally FP, Gorbach SL.
    Clin Ther; 1983 Jul 19; 5(6):603-16. PubMed ID: 6313195
    [Abstract] [Full Text] [Related]

  • 18. [In vitro activity of ceftizoxime on hospital bacteria. Results of a multicenter study].
    Soussy CJ, Deforges L, Le Van Thoi J, Thabaut A, Meyran M, Chanal M, Cluzel M, Brun Y, Coulet M, Fleurette J.
    Pathol Biol (Paris); 1984 May 19; 32(5):326-30. PubMed ID: 6330645
    [Abstract] [Full Text] [Related]

  • 19. Effect of new susceptibility breakpoints on reporting of resistance in Streptococcus pneumoniae--United States, 2003.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2004 Feb 27; 53(7):152-4. PubMed ID: 14985653
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactams.
    Pottumarthy S, Yu Y, Sader HS, Jones RN, Chen M.
    Diagn Microbiol Infect Dis; 2005 Oct 27; 53(2):131-41. PubMed ID: 15939566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.